Related Experiment Video
Updated: Mar 10, 2026
Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
Published on: March 28, 2025
Diagnosis and Medication Treatment of Pediatric Hypertension: A Retrospective Cohort Study
David C Kaelber1,2,3, Weiwei Liu4,5, Michelle Ross4,6
1Comparative Effectiveness Research Through Collaborative Electronic Reporting (CER) Consortium Research Team, Elk Grove Village; Illinois; david.kaelber@case.edu.
Insights
Pediatric hypertension and prehypertension are underdiagnosed in primary care. Current guidelines for diagnosing and managing abnormal blood pressure in children are not consistently followed.
Area of Science:
- Pediatric Cardiology
- Public Health
- Primary Care Medicine
Background:
- Pediatric hypertension increases risk for adult hypertension and early cardiovascular disease.
- Large-scale studies on pediatric hypertension diagnosis and management are lacking.
- Early identification and management are crucial for long-term health outcomes.
Purpose of the Study:
- To evaluate the diagnosis rates of pediatric hypertension and prehypertension in primary care settings.
- To assess the initial medication management of diagnosed pediatric hypertension.
- To identify factors associated with diagnosis and treatment patterns.
Main Methods:
- Retrospective cohort study utilizing electronic health records from over 1.2 million pediatric patients.
- Analysis of demographic, diagnosis, blood pressure, height, weight, and medication data.
- Application of marginal standardization via logistic regression to determine adjusted diagnosis rates.
Main Results:
- 3.3% of pediatric patients met hypertension criteria, and 10.1% met prehypertension criteria.
- Only 23.2% of hypertensive and 10.2% of prehypertensive patients were diagnosed.
- Less than 6% of diagnosed hypertensive children received antihypertensive medication within 12 months.
Conclusions:
- Diagnosis and initial management of pediatric hypertension and prehypertension are infrequent in primary care.
- Current clinical guidelines for abnormal blood pressure in children are not routinely implemented.
- Further research and improved adherence to guidelines are needed to address this public health issue.
Background And Objectives:
Pediatric hypertension predisposes children to adult hypertension and early markers of cardiovascular disease. No large-scale studies have examined diagnosis and initial medication management of pediatric hypertension and prehypertension. The objective of this study was to evaluate diagnosis and initial medication management of pediatric hypertension and prehypertension in primary care.
Methods:
Retrospective cohort study aggregating electronic health record data on >1.2 million pediatric patients from 196 ambulatory clinics across 27 states. Demographic, diagnosis, blood pressure (BP), height, weight, and medication prescription data extracted. Main outcome measures include proportion of pediatric patients with ≥3 visits with abnormal BPs, documented hypertension and prehypertension diagnoses, and prescribed antihypertensive medications. Marginal standardization via logistic regression produced adjusted diagnosis rates.
Results:
Three hundred ninety-eight thousand seventy-nine patients, ages 3 to 18, had ≥3 visits with BP measurements (48.9% girls, 58.6% <10 years old). Of these, 3.3% met criteria for hypertension and 10.1% for prehypertension. Among practices with ≥50 eligible patients, 2813 of 12 138 patients with hypertension (23.2%; 95% confidence interval, 18.2%-28.2%) and 3990 of 38 874 prehypertensive patients (10.2%; 95% confidence interval, 8.2%-12.2%) were diagnosed. Age, weight, height, sex, and number and magnitude of abnormal BPs were associated with diagnosis rates. Of 2813 diagnosed, persistently hypertensive patients, 158 (5.6%) were prescribed antihypertensive medication within 12 months of diagnosis (angiotensin-converting enzyme inhibitors/angiotensin receptive blockers [35%], diuretics [22%], calcium channel blockers [17%], and β-blockers [10%]).
Conclusions:
Hypertension and prehypertension were infrequently diagnosed among pediatric patients. Guidelines for diagnosis and initial medication management of abnormal BP in pediatric patients are not routinely followed.
Related Concept Videos
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
01:23Hypertension V: Nursing Management
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
01:28Hypertension I: Introduction
01:18Hypertension and Regulation of Blood Pressure
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...